DNA testing in primary care 'will transform treatment and cut costs'

Genotype-guided dosing of warfarin in primary care can improve patient outcomes and slash NHS spending on anticoagulants, according to a genetics expert.

Professor Sir John Burn (Photo: Pete Hill)
Professor Sir John Burn (Photo: Pete Hill)

Clinical geneticist Professor Sir John Burn told GPs at the 2014 RCGP annual conference in Liverpool that the breakthrough could transform prescribing in primary care, as point-of-care DNA testing becomes cheaper and more convenient.

Professor Burn, from Newcastle University, said it was now possible to test a patient’s genetic sensitivity to warfarin within 20 minutes for just £20, and the technology could soon be available in primary care.

The same machine will let the GP know the correct dose of warfarin for a patient.

Professor Burn said this would greatly improve outcomes. ‘It’s like saying, don’t buy shoes until you know what size your feet are. You wouldn’t just take away a size seven and hope it fits,’ he said.

‘There are two genes involved in warfarin metabolism. We know that there are three very common variants [of these genes] in our population. If you test for those three variants, you can accurately predict people’s [required] dosage.’

Recent NICE guidance for AF recommended wider use of novel oral anticoagulants (NOACs) as alternatives to warfarin, which requires regular monitoring and is difficult to dose correctly.,/p>

But there are fears this is driving up NHS spending, as these treatments are estimated to cost more than three times the price of warfarin.

‘We can't afford to put everyone on NOACs and we don’t need to,’ said Professor Burn. ‘What we’re trying to do is demonstrate that warfarin can continue to be used if you genotype people.’

Professor Burn and his team have started to roll a scheme to trial point-of-care testing and genotype-led dosage adjustment in Newcastle.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Under 40s to be offered alternative to AstraZeneca COVID-19 vaccine

Under 40s to be offered alternative to AstraZeneca COVID-19 vaccine

Patients aged 30-39 will be offered an alternative to the Oxford/AstraZeneca COVID-19...

GPs per patient down 10% in just five years, NHS data reveal

GPs per patient down 10% in just five years, NHS data reveal

The number of fully-qualified, full-time equivalent (FTE) GPs per patient in England...

Supportive model must replace harmful CQC inspections, BMA chair warns

Supportive model must replace harmful CQC inspections, BMA chair warns

CQC inspections that ‘divert time away from patient care’ and ‘instil fear’ among...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

A 'tsunami' of work is drowning general practice: GPs speak out about a profession at its limit

A 'tsunami' of work is drowning general practice: GPs speak out about a profession at its limit

Rocketing workloads created by huge backlogs of cases and continuing COVID-19 disruption...

Slight increase in GP workforce during past year, but number of partners continues to fall

Slight increase in GP workforce during past year, but number of partners continues to fall

The GP workforce grew by 0.4% in the year to March 2021, but the number of GP partners...